UNCY

Unicycive Therapeutics
$5.13
−$0.27 (−5%)Jul 27, 2026
1.4PoorMoatMint rating

MoatMint rates Unicycive Therapeutics (UNCY) 1.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.2 out of 10.

Key metrics

The numbers that frame UNCY today
Market cap
$136.97M
P/E (TTM)
-3.4
EV / FCF
-3.5
ROIC
2,005.2%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.71
52wk High
$8.74

UNCY stock rating

How UNCY scores on quality, value, growth, momentum and financial health
1.4out of 10
Low overallNeutral business, expensive priceTop 86% of ~5,000 US stocks
QualityPoor0.2/10
GrowthPoor0.1/10
MomentumGreat8.9/10
ValuePoor1.1/10
Financial HealthPoor1.7/10

Growth

Revenue and earnings trend for UNCY
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about UNCY
Is Unicycive Therapeutics a good buy?
No. Unicycive Therapeutics has excellent momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Unicycive Therapeutics is selling at a very high price.
What is the market capitalization of UNCY?
Unicycive Therapeutics's market capitalization is $136.97M.
What is the P/E ratio for UNCY stock?
Unicycive Therapeutics's current P/E ratio is -3.4.
What is the 52-week high for UNCY stock?
The 52-week high for Unicycive Therapeutics is $8.74. The current close of $5.13 is 41.3% below that high.
What is the 52-week low for UNCY stock?
The 52-week low for Unicycive Therapeutics is $3.71. The current close of $5.13 is 38.3% above that low.
Does UNCY stock pay dividends?
Unicycive Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for UNCY?
Unicycive Therapeutics's Debt / Equity ratio is 0.02.